Cited by 404Cancer, Lipids, and MetabolismLipid metabolism and biosynthesisCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer

Migita, Toshiro, Narita, Tadahito, Nomura, Kimie, Miyagi, Erika, Inazuka, Fumika, Matsuura, Masaaki, Ushijima, Masaru, Mashima, Tetsuo, Seimiya, Hiroyuki, Satoh, Yukitoshi, Okumura, Sakae, Nakagawa, Ken, Ishikawa, Yuichi·2008·Cancer Research

DOI 10.1158/0008-5472.can-08-1235

Open this paper in CoChat — free account

Abstract

Enhanced glucose and lipid metabolism is one of the most common properties of malignant cells. ATP citrate lyase (ACLY) is a key enzyme of de novo fatty acid synthesis responsible for generating cytosolic acetyl-CoA and oxaloacetate. To evaluate its role in lung cancer progression, we here analyzed ACLY expression in a subset of human lung adenocarcinoma cell lines and showed a relationship with the phosphatidyl-inositol-3 kinase–Akt pathway. The introduction of constitutively active Akt into cells enhanced the phosphorylation of ACLY, whereas dominant-negative Akt caused attenuation. In human lung adenocarcinoma samples, ACLY activity was found to be significantly higher than in normal lung tissue. Immunohistochemical analysis further showed phosphorylated ACLY overexpression in 162 tumors, well-correlating with stage, differentiation grade, and a poorer prognosis. Finally, to show the therapeutic potential and mechanism of ACLY inhibition for lung cancer treatment, we assessed the effect of RNA interference targeting ACLY on lipogenesis and cell proliferation in A549 cells. ACLY inhibition resulted in growth arrest in vitro and in vivo. Interestingly, increased intracellular lipids were found in ACLY knockdown cells, whereas de novo lipogenesis was inhibited. Supplementation of insulin could rescue the proliferative arrest elicited by ACLY inhibition; however, in contrast, fatty acid palmitate induced cell death. Taken together, these findings suggest that ACLY is involved in lung cancer pathogenesis associated with metabolic abnormality and might offer a novel therapeutic target. [Cancer Res 2008;68(20):8547–54]

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-08-1235

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2003) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,489
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,546
Histological Typing of Lung and Pleural Tumours
Travis, W. D., Colby, T. V., CORRIN, B., Shimosato, Y., & Brambilla, E. M. (1999) · Springer eBooks · doi:10.1007/978-3-642-60049-4 · Cited by 1,534
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Large-scale characterization of HeLa cell nuclear phosphoproteins
Beausoleil, S. A., Jedrychowski, M. P., Schwartz, D., Elias, J. E., Villén, J., Li, J., Cohn, M. A., Cantley, L. C., & Gygi, S. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404720101 · Cited by 1,376

Show all 45 references

Sorted by citations

Items 101–200 of 404

ACSL 3 promotes intratumoral steroidogenesis in prostate cancer cells
Migita, T., Takayama, K., Urano, T., Obinata, D., Ikeda, K., Soga, T., Takahashi, S., & Inoue, S. (2017) · Cancer Science · doi:10.1111/cas.13339 · Cited by 74
Self-citation
Identification of c‐Src tyrosine kinase substrates in platelet‐derived growth factor receptor signaling
Amanchy, R., Zhong, J., Hong, R., Kim, J. H., Guček, M., Cole, R. N., Molina, H., & Pandey, A. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2009.07.001 · Cited by 70
ATP citrate lyase expression is associated with advanced stage and prognosis in gastric adenocarcinoma.
Qian, X., Hu, J., Zhao, J., & Chen, H. (2015) · Europe PMC (PubMed Central) · Cited by 72
Demethoxycurcumin Inhibits Energy Metabolic and Oncogenic Signaling Pathways through AMPK Activation in Triple-Negative Breast Cancer Cells
Shieh, J., Chen, Y., Lin, Y., Lin, J.-N., Chen, W.-C., Chen, Y., Ho, C., & Way, T. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf4012455 · Cited by 70
Role of tyrosine phosphorylation in modulating cancer cell metabolism
Taddei, M. L., Pardella, E., Pranzini, E., Raugei, G., & Paoli, P. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188442 · Cited by 70
Multiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction
Zhu, C., Dong, X., Wang, X., Zheng, Y., Qiu, J., Peng, Y., Xu, J., Chai, Z., & Liu, C. (2022) · Genetics Research · doi:10.1155/2022/9282484 · Cited by 70
A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: Preliminary results
Schwartz, S. (2010) · Oncology Reports · doi:10.3892/or_00000778 · Cited by 71
Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice
Wang, Q. A., Li, S., Jiang, L., Zhou, Y., Li, Z., Shao, M., Li, W., & Liu, Y. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003335 · Cited by 70
Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis
Barger, J. F., & Plas, D. R. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0106 · Cited by 65
ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis
Wang, D., Yin, L., Wei, J., Yang, Z.-X., & Jiang, G. (2017) · Tumor Biology · doi:10.1177/1010428317698338 · Cited by 68
Glycerophospholipid Synthesis as a Novel Drug Target Against Cancer
Dolce, V., Cappello, A. R., Lappano, R., & Maggiolini, M. (2011) · Current Molecular Pharmacology · doi:10.2174/1874-470211104030167 · Cited by 69
Cell Metabolomics Reveals Berberine-Inhibited Pancreatic Cancer Cell Viability and Metastasis by Regulating Citrate Metabolism
Liu, J., Luo, X., Guo, R., Jing, W., & Lu, H. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00394 · Cited by 66
ATP-Citrate Lyase Reduction Mediates Palmitate-induced Apoptosis in Pancreatic Beta Cells
Chu, K. Y., Lin, Y., Hendel, A., Kulpa, J. E., Brownsey, R. W., & Johnson, J. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.157172 · Cited by 68
Metabolic changes during ovarian cancer progression as targets for sphingosine treatment
Anderson, A. S., Roberts, P. C., Frisard, M. I., McMillan, R. P., Brown, T. J., Lawless, M. H., Hulver, M. W., & Schmelz, E. M. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.02.017 · Cited by 64
Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer
Osugi, J., Yamaura, T., Muto, S., Okabe, N., Matsumura, Y., Hoshino, M., Higuchi, M., Suzuki, H., & Gotoh, M. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.03.004 · Cited by 67
Demethoxycurcumin Modulates Prostate Cancer Cell Proliferation via AMPK-Induced Down-regulation of HSP70 and EGFR
Hung, C., Su, Y.-H., Lin, H.-Y., Lin, J.-N., Liu, L., Ho, C., & Way, T. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf302754w · Cited by 64
Pharmacological induction of mesenchymal-epithelial transition via inhibition of H2S biosynthesis and consequent suppression of ACLY activity in colon cancer cells
Ascenção, K., Dilek, N., Augsburger, F., Panagaki, T., Zuhra, K., & Szabó, C. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105393 · Cited by 65
The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications
Icard, P., Simula, L., Fournel, L., Leroy, K., Mansuet‐Lupo, A., Damotte, D., Charpentier, M.-C., Durdux, C., Loi, M., Schussler, O., et al. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100852 · Cited by 63
Inter-organelle cross-talk supports acetyl-coenzyme A homeostasis and lipogenesis under metabolic stress
Kuna, R. S., Kumar, A., Gálvez, H., Wessendorf-Rodriguez, K. A., Green, C. R., McGregor, G. H., Cordes, T., Shaw, R. J., Svensson, R. U., & Metallo, C. M. (2023) · Science Advances · doi:10.1126/sciadv.adf0138 · Cited by 63
Cytosolic functions of MORC2 in lipogenesis and adipogenesis
Sánchez‐Solana, B., Li, D., & Kumar, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.11.012 · Cited by 66
ATP Citrate Lyase Inhibitors as Novel Cancer Therapeutic Agents
Zu, X., Zhang, Q., Liu, J., Cao, R.-X., Zhong, J., Yi, G., Quan, Z.-H., & Pizzorno, G. (2012) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489212799972954 · Cited by 64
Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells
Li, Z., Li, D., Choi, E. Y., Lapidus, R. G., Zhang, L., Huang, S. M., Shapiro, P., & Wang, H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.783860 · Cited by 62
ATP ‐citrate lyase regulates cellular senescence via an AMPK ‐ and p53‐dependent pathway
Lee, J., Jang, H., Lee, S., Lee, J., Choi, J., Kim, T. W., Cho, E., & Youn, H. (2014) · FEBS Journal · doi:10.1111/febs.13139 · Cited by 62
Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway
Wei, X., Shi, J., Lin, Q., Ma, X., Pang, Y., Mao, H., Li, R., Lü, W., Wang, Y., & Liu, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.642229 · Cited by 60
The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells
Kwan, H. Y., Yang, Z., Fong, W. F., Hu, Y., Yu, Z., & Hsiao, W. L. W. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0612-1 · Cited by 61
Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis
Kumari, R., Deshmukh, R. S., & Das, S. (2019) · Nature Communications · doi:10.1038/s41467-019-12194-6 · Cited by 60
Nitric oxide and tumor metabolic reprogramming
Lopez-Sanchez, L. M., Aranda, E., & Rodríguez‐Ariza, A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113769 · Cited by 63
Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells
Migita, T., Okabe, S., Ikeda, K., Igarashi, S., Sugawara, S., Tomida, A., Soga, T., Taguchi, R., & Seimiya, H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28652 · Cited by 61
Self-citation
Metabolic control of signalling pathways and metabolic auto‐regulation
Lorendeau, D., Christen, S., Rinaldi, G., & Fendt, S. (2015) · Biology of the Cell · doi:10.1111/boc.201500015 · Cited by 60
Inhibitors of lipogenic enzymes as a potential therapy against cancer
Montesdeoca, N., López, M., Ariza, X., Herrero, L., & Makowski, K. (2020) · The FASEB Journal · doi:10.1096/fj.202000705r · Cited by 58
Inhibition of ACLY Leads to Suppression of Osteoclast Differentiation and Function Via Regulation of Histone Acetylation
Guo, Q., Kang, H., Wang, J., Dong, Y., Peng, R., Zhao, H., Wu, W., Guan, H., & Li, F. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4399 · Cited by 58
Targeting citrate as a novel therapeutic strategy in cancer treatment
Huang, L., Wang, C., Xu, H., & Peng, G. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188332 · Cited by 60
Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer
Wang, Y., Wang, Y., Shen, L., Pang, Y., QIAO, Z., & Liu, P. (2012) · Oncology Reports · doi:10.3892/or.2012.1638 · Cited by 59
Essential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesis
Kalainayakan, S. P., FitzGerald, K. E., Konduri, P. C., Vidal, C., & Li, Z. (2018) · Cell & Bioscience · doi:10.1186/s13578-018-0257-8 · Cited by 59
Immunometabolism in cancer: basic mechanisms and new targeting strategy
Su, R., Shao, Y., Huang, M., Liu, D., Yu, H., & Qiu, Y. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02006-2 · Cited by 62
Inhibition of ATP Citrate Lyase Induces an Anticancer Effect via Reactive Oxygen Species
Migita, T., Okabe, S., Ikeda, K., Igarashi, S., Sugawara, S., Tomida, A., Taguchi, R., Soga, T., & Seimiya, H. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.048 · Cited by 58
Self-citation
Antitumor effects of curcumin: A lipid perspective
Naeini, M. B., Momtazi‐Borojeni, A. A., Jaafari, M. R., Johnston, T. P., Barreto, G. E., Banach, M., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28262 · Cited by 57
Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression
Marimuthu, S., Rauth, S., Ganguly, K., Zhang, C., Lakshmanan, I., Batra, S. K., & Ponnusamy, M. P. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09959-1 · Cited by 55
Acetyl-CoA derived from hepatic mitochondrial fatty acid β-oxidation aggravates inflammation by enhancing p65 acetylation
Chen, Q., Du, J., Cui, K., Fang, W. Y., Zhao, Z., Chen, Q., Mai, K., & Ai, Q. (2021) · iScience · doi:10.1016/j.isci.2021.103244 · Cited by 55
Ubiquitination Links DNA Damage and Repair Signaling to Cancer Metabolism
Koo, S.-Y., Park, E., Noh, H.-J., Jo, S.-M., Ko, B.-K., Shin, H.-J., & Lee, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098441 · Cited by 60
Dehydrocostus lactone suppresses gastric cancer progression by targeting ACLY to inhibit fatty acid synthesis and autophagic flux
Chen, Y., Shen, J., Yuan, M., Li, H., Li, Y., Zheng, S., Han, B., Zhang, C., Liu, S.-L., Sun, Q., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.01.028 · Cited by 56
De novo lipogenesis represents a therapeutic target in mutant Kras non‐small cell lung cancer
Singh, A., Ruiz, C. F., Bhalla, K., Haley, J. D., Li, Q. K., Acquaah-Mensah, G. K., Montal, E. D., Sudini, K. R., Skoulidis, F., Wistuba, I. I., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800204 · Cited by 60
ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
Liu, D., Zhang, T., Chen, X., Zhang, B., Wang, Y., Xie, M., Ji, X., Sun, M., Huang, W., & Xia, L. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04410-3 · Cited by 54
Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function
Ward, N. P., Kang, Y. P., Falzone, A., Boyle, T. A., & DeNicola, G. M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191689 · Cited by 55
ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p‐eIF2α/ATF4/CHOP axis
Zheng, Y., Zhou, Q., Zhao, C., Li, J., Yu, Z., & Zhu, Q. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16235 · Cited by 53
Sterol regulatory element-binding protein 1 is required for ovarian tumor growth
NIE, L.-Y., Lü, Q., Li, W., YANG, N., Dongol, S., Zhang, X., & Jiang, J. (2013) · Oncology Reports · doi:10.3892/or.2013.2575 · Cited by 56
ACLY: A biomarker of recurrence in breast cancer
Chen, Y., Li, K., Gong, D., Zhang, J., Li, Q., Zhao, G., & Lin, P. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153076 · Cited by 53
Tumor metabolic reprogramming in lung cancer progression (Review)
Li, X., Liu, M., Liu, H., & Chen, J. (2022) · Oncology Letters · doi:10.3892/ol.2022.13407 · Cited by 52
Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
Pyragius, C. E., Fuller, M., Ricciardelli, C., & Oehler, M. K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14047742 · Cited by 51
PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma
Wartewig, T., Daniels, J., Schulz, M., Hameister, E., Joshi, A., Park, J., Morrish, E., Venkatasubramani, A. V., Cernilogar, F. M., van Heijster, F. H. A., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00635-7 · Cited by 54
Targeting Cell Metabolism as Cancer Therapy
Ngoi, N. Y. L., Eu, J. Q., Hirpara, J. L., Wang, L., Lim, J. S. J., Lee, S. C., Lim, Y., Pervaiz, S., Goh, B. C., & Wong, A. L. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7947 · Cited by 52
Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties
Hatamipour, M., Ramezani, M., Tabassi, S. A. S., Johnston, T. P., Ramezani, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27029 · Cited by 50
Nonhistone targets of KAT2A and KAT2B implicated in cancer biology
Bondy‐Chorney, E., Denoncourt, A. M., Sai, Y., & Downey, M. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0297 · Cited by 50
Activation of ATP Citrate Lyase by mTOR Signal Induces Disturbed Lipid Metabolism in Hepatitis B Virus Pre-S2 Mutant Tumorigenesis
Teng, C., Wu, H., Hsieh, W.-C., Tsai, H.-W., & Su, I. (2014) · Journal of Virology · doi:10.1128/jvi.02363-14 · Cited by 48
Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma
Lu, J., Zhang, Y., Sun, M., Ding, C., Zhang, L., Kong, Y., Cai, M., Miccoli, P., Ma, C., & Yue, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.737127 · Cited by 48
mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancer
Chen, Y., Qian, J., He, Q., Zhao, H., Toral‐Barza, L., Shi, C., Zhang, X., Wu, J., & Yu, K. (2016) · Oncotarget · doi:10.18632/oncotarget.8279 · Cited by 50
Cancer cell metabolism connects epigenetic modifications to transcriptional regulation
Morrison, A. J. (2021) · FEBS Journal · doi:10.1111/febs.16032 · Cited by 47
Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression
Noh, K. H., Kang, H. M., Yoo, W., Min, Y. H., Kim, D., Kim, M., Wang, S., Lim, J. H., & Jung, C. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154302 · Cited by 46
Theoretical framework and emerging challenges of lipid metabolism in cancer
Gu, Q., Wang, Y., Yi, P., & Cheng, C. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.12.002 · Cited by 45
ATP citrate lyase activity is post‐translationally regulated by sink strength and impacts the wax, cutin and rubber biosynthetic pathways
Xing, S., van Deenen, N., Magliano, P., Frahm, L., Forestier, E. C. F., Nawrath, C., Schaller, H., Gronover, C. S., Prüfer, D., & Poirier, Y. (2014) · The Plant Journal · doi:10.1111/tpj.12559 · Cited by 45
Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma
Monteiro, M. S., Barros, A. S., Pinto, J., Carvalho, M. C., Luís, A. S., Henrique, R., Jerónimo, C., Bastos, M. D. L., Gil, A. M., & de Pinho, P. G. (2016) · Scientific Reports · doi:10.1038/srep37275 · Cited by 45
ACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate
Keenan, M. M., Liu, B., Tang, X., Wu, J., Cyr, D. D., Stevens, R. D., Ilkayeva, O., Huang, Z., Tollini, L. A., Murphy, S. K., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005599 · Cited by 43
Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials
Troncone, M. J., Cargnelli, S., Villani, L. A., Isfahanian, N., Broadfield, L. A., Zychla, L., Wright, J., Pond, G. R., Steinberg, G. R., & Tsakiridis, T. K. (2017) · Oncotarget · doi:10.18632/oncotarget.17496 · Cited by 45
Metabolic Signaling to Epigenetic Alterations in Cancer
Kim, J., & Yeom, Y. I. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.185 · Cited by 45
Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change
Zhou, Z., Ibekwe, E., & Chornenkyy, Y. (2018) · Antioxidants · doi:10.3390/antiox7010016 · Cited by 44
Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly
Csanádi, Á., Kayser, C., Donauer, M., Gumpp, V., Aumann, K., Rawluk, J. K., Prasse, A., Hausen, A. Z., Wiesemann, S. D., Werner, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126357 · Cited by 44
PPARδ Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis
Pollock, C. B., Yin, Y., Yuan, H., Zeng, X., King, S., Li, X., Kopelovich, L., Albanese, C., & Glazer, R. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016215 · Cited by 43
ACLY ubiquitination by CUL3-KLHL25 induces the reprogramming of fatty acid metabolism to facilitate iTreg differentiation
Tian, M., Hao, F., Jin, X., Sun, X. J., Jiang, Y., Wang, Y., Li, D., Chang, T., Zou, Y., Peng, P., et al. (2021) · eLife · doi:10.7554/elife.62394 · Cited by 41
Role of Insulin-Like Growth Factor Binding Protein 2 in Lung Adenocarcinoma
Migita, T., Narita, T., Asaka, R., Miyagi, E., Nagano, H., Nomura, K., Matsuura, M., Satoh, Y., Okumura, S., Nakagawa, K., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090500 · Cited by 41
Self-citation
Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells inï¿½vitro
Teng, L. L., Chen, Y., Cao, Y. W., Wang, W., Xu, Y., Wang, Y., Jia-yin, L., Li, C., & Su, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.8211 · Cited by 41
mTOR Complexes as a Nutrient Sensor for Driving Cancer Progression
Harachi, M., Masui, K., Okamura, Y., Tsukui, R., Mischel, P. S., & Shibata, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103267 · Cited by 43
Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity
Chittaranjan, S., Chan, S. Y., Yang, C. P., Yang, K., Chen, V., Moradian, A., Firme, M. R., Song, J., Go, N. E., Blough, M. D., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2401 · Cited by 44
Nuclear localization of metabolic enzymes in immunity and metastasis
He, Y., Gao, M., Cao, Y., Tang, H., Liu, S., & Tao, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.07.002 · Cited by 40
Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer
Pei, L., Liu, H., Ouyang, S., Zhao, C., Liu, M., Wang, T., Wang, P., Ye, H., Wang, K., Song, C., et al. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.11.026 · Cited by 40
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Patra, S., Elahi, N., Armorer, A., Arunachalam, S., Omala, J., Hamid, I., Ashton, A. W., Joyce, D. A., Jiao, X., & Pestell, R. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700629 · Cited by 43
Lipid Synthesis Is a Metabolic Liability of Non–Small Cell Lung CancerPreprint
Svensson, R. U., & Shaw, R. J. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030874 · Cited by 40
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer
Nava, G. M., & Pérez, L. A. M. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2065196 · Cited by 40
mTOR complex 2 is an integrator of cancer metabolism and epigenetics
Masui, K., Harachi, M., Cavenee, W. K., Mischel, P. S., & Shibata, N. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.03.001 · Cited by 39
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance
Polónia, B. R. G., Xavier, C. P. R., Kopecka, J., Riganti, C., & Vasconcelos, M. H. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.05.001 · Cited by 39
RBM25 is required to restrain inflammation via ACLY RNA splicing-dependent metabolism rewiring
Zhang, Y., Gao, Y., Wang, Y., Jiang, Y., Yan, X. Y., Wang, X., Wang, Z., Ding, Y., Chen, H., Rui, B., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01212-3 · Cited by 38
Managing lipid metabolism in proliferating cells: New perspective for metformin usage in cancer therapy
Lettieri‐Barbato, D., Vegliante, R., Desideri, E., & Ciriolo, M. R. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.02.003 · Cited by 39
Long Noncoding RNA CTD-2245E15.3 Promotes Anabolic Enzymes ACC1 and PC to Support Non–Small Cell Lung Cancer Growth
Wang, C., Meng, X., Zhou, Y., Yu, J., Li, Q., Liao, Z., Gu, Y., Han, J., Linghu, S., Jiao, Z., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-19-3806 · Cited by 38
Cytoplasmic Endonuclease G promotes nonalcoholic fatty liver disease via mTORC2-AKT-ACLY and endoplasmic reticulum stress
Wang, W., Tan, J., Liu, X., Guo, W., Li, M., Liu, X., Liu, Y., Dai, W., Hu, L., Wang, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41757-x · Cited by 39
Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review
Wang, Q., Liu, J., Chen, Z., Zheng, J., Wang, Y., & Dong, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116021 · Cited by 44
Targeting stearoyl-CoA desaturase 1 to repress endometrial cancer progression
Li, W., Bai, H., Liu, S., Cao, D., Wu, H., Shen, K., Tai, Y., & Yang, J. (2018) · Oncotarget · doi:10.18632/oncotarget.24304 · Cited by 37
The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease
Park, G. S. H., Jung, S., Wellen, K. E., & Jang, C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00614-x · Cited by 37
The Heterogeneity of Lipid Metabolism in Cancer
Park, J. K., Coffey, N. J., Limoges, A., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_3 · Cited by 38
Biochemical changes accompanying apoptotic cell death in retinoblastoma cancer cells treated with lipogenic enzyme inhibitors
Vandhana, S., Coral, K., Jayanthi, U., Deepa, P. R., & Krishnakumar, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.06.005 · Cited by 36
HMGA1 Drives Metabolic Reprogramming of Intestinal Epithelium during Hyperproliferation, Polyposis, and Colorectal Carcinogenesis
Williams, M. D., Zhang, X., Belton, A., Xian, L., Huso, T. H., Park, J.-J., Siems, W. F., Gang, D. R., Resar, L. M. S., Reeves, R., et al. (2015) · Journal of Proteome Research · doi:10.1021/pr501084s · Cited by 36
ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells
Huang, S.-S., Tsai, C., Kuo, C., Li, Y.-S., & Cheng, S. (2022) · Endocrine · doi:10.1007/s12020-022-03124-6 · Cited by 36
TCA cycle-derived oncometabolites in cancer and the immune microenvironment
Sarkar, S., Chang, C.-I., Jean, J., & Wu, M. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01186-y · Cited by 39
miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPARγ in gastric cancer
Cheng, Y., Jia, B., Wang, Y., & Wan, S. (2017) · Oncology Reports · doi:10.3892/or.2017.5944 · Cited by 34
Pistacia lentiscus Hydrosol: Untargeted Metabolomic Analysis and Anti-Inflammatory Activity Mediated by NF-κB and the Citrate Pathway
Santarsiero, A., Onzo, A., Pascale, R., Acquavia, M. A., Coviello, M., Convertini, P., Todisco, S., Marsico, M., Pifano, C., Iannece, P., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4264815 · Cited by 33
Regulation of tumor metabolism by post translational modifications on metabolic enzymes
Dessai, A. S., Kalhotra, P., Novickis, A. T., & Dasgupta, S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00521-x · Cited by 38
MiR-22 down-regulates the proto-oncogene ATP citrate lyase to inhibit the growth and metastasis of breast cancer.
Liu, H., Huang, X., & Tian, Y. (2018) · PubMed Central · Cited by 33
SLC25A1 and ACLY maintain cytosolic acetyl-CoA and regulate ferroptosis susceptibility via FSP1 acetylation
Li, W., Han, J., Huang, B., Xu, T., Wan, Y., Luo, D., Kong, W., Yu, Y. H., Zhang, L., Nian, Y., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00369-5 · Cited by 39
A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer
Zhelev, Z., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2339584 · Cited by 34
Glutamine, Glucose and other Fuels for Cancer
Ruiz-Pérez, M. V., Sánchez‐Jiménez, F., Alonso, F. J., Segura, J., Márquez, J., & Medina, M. Á. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990482 · Cited by 31
Glutamine Deprivation Enhances Acetyl-CoA Carboxylase Inhibitor-induced Death of Human Pancreatic Cancer Cells
Nishi, K., Suzuki, M., YAMAMOTO, N., Matsumoto, A., Iwase, Y., Yamasaki, K., Otagiri, M., & Yumita, N. (2018) · Anticancer Research · doi:10.21873/anticanres.13036 · Cited by 33
Expression and clinicopathological significance of lipin‐1 in human breast cancer and its association with p53 tumor suppressor gene
Dinarvand, N., Khanahmad, H., Hakimian, S. M., Sheikhi, A., Rashidi, B., Bakhtiari, H., & Pourfarzam, M. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29523 · Cited by 31

Authors: Migita, T., Narita, T., Nomura, K., Miyagi, E., Inazuka, F., Matsuura, M., Ushijima, M., Mashima, T., Seimiya, H., Satoh, Y., Okumura, S., Nakagawa, K., & Ishikawa, Y.
Affiliations: 1Pathology and Divisions of
Zenyaku Kogyo (Japan) (JP)
2Cancer Genomics, The Cancer Institute,
3Bioinformatics Group, Genome Center,
4Division of Molecular Biotherapy, Cancer Chemotherapy Center,
The Cancer Institute Hospital (JP)
ORCID: Migita, Toshiro
Ushijima, Masaru
Mashima, Tetsuo
Seimiya, Hiroyuki
Satoh, Yukitoshi
Nakagawa, Ken
Ishikawa, Yuichi
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2008-10-15
Volume: 68
Issue: 20
Pages: 8547-8554
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-08-1235
OpenAlex: W2136765222
Cited by: 403
References: 45
Citations by year: 2026: 17 · 2025: 16 · 2024: 32 · 2023: 26 · 2022: 36 · 2021: 48 · 2020: 34 · 2019: 24 · 2018: 25 · 2017: 21 · 2016: 17 · 2015: 21 · 2014: 20 · 2013: 22 · 2012: 17
FWCI: 2.93
Type: journal article
Language: en
Open access: closed
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: ATP citrate lyase, non-small cell lung cancer, lung adenocarcinoma, de novo lipogenesis, lipogenesis, Akt signaling, PI3K/Akt signaling, acetyl-CoA, cancer metabolism, RNA interference, insulin, palmitate, cell proliferation, prognostic factors, therapeutic target
MeSH terms: Adenocarcinoma, Animals, ATP Citrate (pro-S)-Lyase, Carcinoma, Non-Small-Cell Lung, Enzyme Activation, Humans, Lung Neoplasms, Phosphorylation, Prognosis, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks